|
Alectinib Hydrochloride
|
|
1256589-74-8
|
|
AZD1208
|
|
1204144-28-4
|
|
Ombitasvir
|
|
1258226-87-7
|
|
Tegatrabetan
|
|
1227637-23-1
|
|
EGFR-IN-7 (compound 34)
|
|
2267329-76-8
|
|
THPP-1
|
|
1257051-63-0
|
|
DT2216
|
|
2365172-42-3
|
|
GDC-0879
|
|
905281-76-7
|
|
DWK-1339
|
|
1018946-38-7
|
|
AP26113
|
|
1197958-12-5
|
|
Omaveloxolone (RTA-408)
|
|
1474034-05-3
|
|
Solcitinib
|
|
1206163-45-2
|
|
ESI-09
|
|
263707-16-0
|
|
PRT 060318
|
|
1194961-19-7
|
|
Avapritinib (BLU-285)
|
|
1703793-34-3
|
|
LMP744
|
|
308246-52-8
|
|
Imaradenant (AZD4635)
|
|
1321514-06-0
|
|
AMPA/kainate antagonist-2
|
|
923271-87-8
|
|
Topotecan
|
|
123948-87-8
|
|
Vipivotide tetraxetan (PSMA-617)
|
|
1702967-37-0
|
|
Fantofarone
|
|
114432-13-2
|
|
Poziotinib
|
|
1092364-38-9
|
|
ACY-775
|
|
1375466-18-4
|
|
MRT68921 HCl
|
|
1190379-70-4
|
|
Avitinib (AC0010)
|
|
1557267-42-1
|
|
GSK180736A (GSK180736)
|
|
817194-38-0
|
|
BI-3802
|
|
2166387-65-9
|
|
NIK SMI1
|
|
1660114-31-7
|
|
5-(5-((1S,2R)-2-isopropylcyclopropyl)-6-methylpyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione
|
|
2375815-63-5
|
|
Granisetron
|
|
109889-09-0
|
|
AZ3976
|
|
1418747-15-5
|
|
Doramapimod
|
|
285983-48-4
|
|
Dovitinib (TKI258) Lactate
|
|
915769-50-5
|
|
Unii-na83F1sjsr
|
|
706782-28-7
|
|
Daclatasvir Dihydrochloride
|
|
1009119-65-6
|
|
Cobimetinib
|
|
934660-93-2
|
|
N-[2-[6-[[(3,4-Dichlorophenyl)Methyl]aMino]-2-(4-Methoxyphenyl)-3-oxopyrido[2,3-b]pyrazin-4(3H)-yl]ethyl]-acetaMide
|
|
1018674-83-3
|
|
Peficitinib
|
|
944118-01-8
|
|
Elimusertib
|
|
1876467-74-1
|
|
SR59230A
|
|
174689-39-5
|
|
ETC-206 (AUM 001)
|
|
1464151-33-4
|
|
TTK21
|
|
709676-56-2
|
|
JHU-083
|
|
1998725-11-3
|
|
BRD4 Inhibitor-10
|
|
1660117-38-3
|
|
Pyridone6
|
|
457081-03-7
|
|
NVP-TNKS656
|
|
1419949-20-4
|
|
HO-3867
|
|
1172133-28-6
|
|
Ozanimod (RPC1063)
|
|
1306760-87-1
|
|
MIK665
|
|
1799631-75-6
|
|
CID 1375606
|
|
313493-80-0
|
|
DLinDMA
|
|
871258-12-7
|
|
MPP+ iodide
|
|
36913-39-0
|
|
CC-92480
|
|
2259648-80-9
|
|
GSK962
|
|
2049872-86-6
|
|
TCS PIM-1 1
|
|
491871-58-0
|
|
Filgotinib (GLPG0634)
|
|
1206161-97-8
|
|
AZD3759
|
|
1626387-80-1
|
|
PLX7904
|
|
1393465-84-3
|
|
YKL06-061
|
|
2172617-15-9
|
|
BI-3812
|
|
2166387-64-8
|
|
ML198
|
|
1380716-06-2
|
|
LYS006hcl
|
|
1799681-85-8
|
|
NVP-BSK805
|
|
1092499-93-8
|
|
2-(2-Chlorophenyl)-4-(3-(diMethylaMino)phenyl)-5-Methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione
|
|
1218942-37-0
|
|
SMCC-DM1
|
|
1228105-51-8
|
|
RAF709
|
|
1628838-42-5
|
|
BMS-986158
|
|
1800340-40-2
|
|
Verteporfin
|
|
129497-78-5
|
|
Z433927330
|
|
1005883-72-6
|
|
1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(4-cyanophenoxy)phenyl)urea
|
|
1313019-65-6
|
|
Dabrafenib mesylate
|
|
1195768-06-9
|
|
Ceritinib dihydrochloride
|
|
1380575-43-8
|
|
Sacubitril/Valsartan
|
|
936623-90-4
|
|
Nk-252
|
|
1414963-82-8
|
|
PH-002
|
|
1311174-68-1
|
|
FIT-039
|
|
1113044-49-7
|
|
AZ9482
|
|
1825345-33-2
|
|
Mobocertinib
|
|
1847461-43-1
|
|
TYK2-IN-4
|
|
1609392-27-9
|
|
P110δ-IN-1,ME401
|
|
1595129-71-7
|
|
Selumetinib (AZD6244)
|
|
606143-52-6
|
|
BAY 61-3606 dihydrochloride
|
|
648903-57-5
|
|
Pacritinib
|
|
937272-79-2
|
|
Lorediplon
|
|
917393-39-6
|
|
BX430
|
|
688309-70-8
|
|
Nedisertib (M3814)
|
|
1637542-33-6
|
|
5-(4-PHENOXYBUTOXY)PSORALEN
|
|
870653-45-5
|
|
Lazertinib
|
|
1903008-80-9
|
|
Dynarrestin
|
|
2222768-84-3
|
|
AZD7648
|
|
2230820-11-6
|
|
GN44028
|
|
1421448-26-1
|
|
Pimasertib (AS-703026)
|
|
1236699-92-5
|
|
AZD-7325
|
|
942437-37-8
|
|
Indotecan
|
|
915303-09-2
|
|
Nilotinib hydrochloride
|
|
923288-95-3
|
|
EED226
|
|
2083627-02-3
|
|
NSC45586
|
|
6300-44-3
|
|
ADX-102
|
|
916056-79-6
|
|
Naltrexone
|
|
16590-41-3
|
|
H 89 2HCl
|
|
130964-39-5
|